Literature DB >> 29976649

Nonadherence with inhaled preventer therapy in severe asthmatic patients on long-term omalizumab.

David J Allen1, Leanne-Jo Holmes1, Kerry A Hince1, Rachael Daly1, Calra Ustabashi1, Gael Tavernier1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29976649     DOI： 10.1183/13993003.01025-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  2 in total

1.  Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics.

Authors:  Marco Caminati; Andrea Vianello; Margherita Andretta; Anna Michela Menti; Silvia Tognella; Luca Degli Esposti; Claudio Micheletto; Chiara Bovo; Gianenrico Senna
Journal:  ERJ Open Res       Date:  2020-04-27

Review 2.  2021 Brazilian Thoracic Association recommendations for the management of severe asthma.

Authors:  Regina Maria de Carvalho-Pinto; José Eduardo Delfini Cançado; Marcia Margaret Menezes Pizzichini; Jussara Fiterman; Adalberto Sperb Rubin; Alcindo Cerci Neto; Álvaro Augusto Cruz; Ana Luisa Godoy Fernandes; Ana Maria Silva Araujo; Daniela Cavalet Blanco; Gediel Cordeiro Junior; Lilian Serrasqueiro Ballini Caetano; Marcelo Fouad Rabahi; Marcelo Bezerra de Menezes; Maria Alenita de Oliveira; Marina Andrade Lima; Paulo Márcio Pitrez
Journal:  J Bras Pneumol       Date:  2021-12-15       Impact factor: 2.624
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.